Omni Boston Seaport, 450 Summer Street, Boston, MA 02210

Virtual

We are delighted to have Dr. Alfred Sandrock as our guest speaker, discussing his experience in the field of drug discovery and development. Dr. Sandrock is President and CEO of Voyager Therapeutics, a company focused on creating disease-modifying neurogenetic medicines. Dr. Sandrock joined Voyager following 23 years at Biogen where he identified and developed novel therapies for a variety of serious diseases. There he served in positions of increasing responsibility, culminating in his service as Executive Vice President, Research and Development. He also served as Chief Medical Officer and held a seat on the Biogen Executive Committee. Over the course of his tenure, he led the discovery, development, and regulatory approval of numerous medicines including ADUHELM , PLEGRIDY®, SPINRAZA®, TECFIDERA®, and TYSABRI®. Prior to joining Biogen, Dr. Sandrock was Assistant Professor of Neurology at Harvard Medical School and was Assistant in Neurology at Massachusetts General Hospital. He earned a B.A. in human biology from Stanford University, an M.D. from Harvard Medical School, and a Ph.D. in neurobiology from Harvard University. Dr. Sandrock completed an internship in medicine, a residency and chief residency in neurology, and a clinical fellowship in neuromuscular disease and clinical neurophysiology at Massachusetts General Hospital.

Assembly Row, Somerville, MA

A two-day intensive, in-person, hands-on healthcare innovation course in the mecca of biomedical innovation - greater Boston - is designed on decades of cutting-edge innovation on the fringes. Suitable for startups, physicians, researchers, investors, allied health professionals, MBAs, students, executives, and the public. A combination of lectures, hands-on cases, extensive networking, lively panels, and startup pitch sessions. CME credits for physicians (14.5 AMA PRA Category 1 Credits ).